CClinicalTrials.gg
Not yet recruitingNCT07807566Updated Sep 8, 2026

Combined Lung and Diaphragmatic Ultrasound to Predict Respiratory Failure in Blunt Chest Trauma

An observational study in Blunt Chest Trauma, Respiratory Failure and Thoracic Injuries, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
130
Ages
18 Years and older
Sex
All
01

Study summary

Blunt chest trauma is a leading cause of emergency hospital visits and can result in severe breathing complications such as hypoxemic respiratory failure. While computed tomography (CT) scans provide detailed imaging of the chest, their routine use is limited by radiation exposure, high cost, and the inability to perform frequent bedside monitoring. Bedside lung ultrasound (LUS) is commonly used to detect structural injuries like lung contusions or collapsed lungs, but it cannot assess how well the breathing muscles are working. Because acute respiratory failure after chest trauma involves both lung tissue damage and impaired breathing muscle mechanics, combining lung ultrasound with diaphragmatic ultrasound may improve early risk assessment.

The primary purpose of this prospective cohort study is to determine whether combining point-of-care lung ultrasound with diaphragmatic ultrasound provides better early prediction of hypoxemic respiratory failure than lung ultrasound alone in adult patients with isolated blunt chest trauma.

Participants will undergo bedside lung ultrasound, diaphragmatic ultrasound, and arterial blood gas testing at four standardized time points: upon hospital admission (baseline), and at 6, 12, and 24 hours after admission. The lung ultrasound examination assesses the degree of lung tissue injury using a standardized 12-zone Lung Ultrasound Score (LUS). Diaphragmatic ultrasound measures muscle movement (diaphragmatic excursion) and contraction strength (diaphragm thickening fraction). Arterial blood gas results will be used to track oxygenation via the PaO2/FiO2 ratio, with a ratio of 300 mmHg or lower defining hypoxemic respiratory failure. All participants will also receive a standard-of-care chest CT scan as a reference comparison.

The study aims to evaluate whether this non-invasive, radiation-free bedside approach helps emergency physicians identify high-risk patients earlier, guiding timely respiratory support and intensive care triage while minimizing the need for repeated CT scans.

02

Conditions studied

  • Blunt Chest Trauma
  • Respiratory Failure
  • Thoracic Injuries
  • Hypoxemic Respiratory Failure

Keywords

  • Lung ultrasound
  • Diaphragmatic ultrasound
  • Diaphragmatic excursion
  • Diaphragm thickening fraction
  • Point-of-care ultrasound
  • POCUS
  • Lung Ultrasound Score
  • Pulmonary contusion
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients presenting to the emergency room of the Trauma Unit at Assiut University Hospitals within 24 hours of sustaining isolated blunt chest trauma.

Inclusion criteria

  • Age 18 years or older
  • Presentation to the trauma unit within 24 hours of injury
  • Diagnosed with isolated blunt chest trauma
  • Willingness to participate with written informed consent provided by the patient or legally authorized representative

Exclusion criteria

Exclusion Criteria:

  • Penetrating chest trauma
  • Immediate endotracheal intubation before baseline ultrasound assessment
  • Massive hemothorax or tension pneumothorax requiring immediate emergency intervention prior to ultrasound evaluation
  • Inadequate ultrasound acoustic window due to extensive subcutaneous emphysema or severe obesity
  • Known preexisting chronic pulmonary disease (e.g., chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, bronchial asthma)
  • Known preexisting cardiac disease (e.g., ischemic heart disease, rheumatic heart disease)
  • Known neuromuscular disorders affecting respiratory muscles
  • Previous thoracic surgery affecting diaphragmatic excursion or documented diaphragmatic paralysis
  • Pregnancy
  • Refusal to provide informed consent or withdrawal from the study
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
130 participants (estimated)
Patient registry
No

Groups and cohorts

  • Isolated Blunt Chest Trauma Patients

    Adult patients presenting within 24 hours of isolated blunt chest trauma. All participants undergo serial bedside point-of-care lung ultrasound (12-zone protocol to calculate total LUS) and diaphragmatic ultrasound (measuring diaphragmatic excursion \[DE\] and diaphragm thickening fraction \[DTF\]), paired with arterial blood gas analysis to calculate the PaO₂/FiO₂ ratio at four predefined time points: admission (baseline), 6 hours, 12 hours, and 24 hours post-admission. Patients also undergo baseline chest CT imaging as a standard reference.

05

What researchers measure

Primary outcomes

  1. Ratio of Arterial Oxygen Partial Pressure to Fractional Inspired Oxygen (PaO2/FiO2)

    PaO2/FiO2 ratio will be calculated using arterial blood gas (ABG) analysis. Hypoxemic respiratory failure is defined as a PaO2/FiO2 ratio of 300 mmHg or less. Values will be measured in mmHg.

    Time frame: 1 day

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07807566
Lead sponsor
Assiut University
Responsible party
Ahmed Mohamed Ahmed Mohamed (Resident at Emergency Department, Assiut University) — Principal investigator
First posted
Sep 8, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 8, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion